The evaluation process focuses on clinically supported dosages that reflect current research, seeking NMN products that deliver the optimal amounts shown in peer-reviewed studies
Proper injection site rotation and monitoring for tirzepatide's gastrointestinal effects remain essential
Among the drugs targeting Gln transporters for DSMTs treatment, only the LAT1 inhibitor JPH203 has entered clinical trials
Over the past 20 years, lipotropics have become a staple in the weight loss industry
Mean change in body weight from baseline to Week 52 was a secondary endpoint.* Statistically significant vs Januvia 100 mg PIONEER 3 study design 1,4 In a double-blind, double-dummy trial with a primary endpoint of mean change in A1C from baseline to 26 weeks, 1864 adult patients with type 2 diabetes on metformin alone or metformin with a sulfonylurea were randomized to RYBELSUS 3 mg (n=466), RYBELSUS 7 mg (n=465), RYBELSUS 14 mg (n=465), or Januvia 100 mg (n=467), all once daily
Want to learn more about these treatments
